摘要
目的探讨血液灌流、血液透析联合治疗比单独血液透析治疗尿毒症的优越性。方法回顾分析46例使用血液灌流血液透析联合治疗患者,随机抽取其中20例,计算肌酐、尿素氮、中分子毒素(middle molecule substances MMS)下降率,患者睡眠、食欲、高血压、皮肤瘙痒等症状改善情况,另以20例单独运用血液透析患者做对照,比较其透析效果。结果血液灌流、血液透析联合治疗患者透后血肌酐和尿素氮均下降60%,顽固性皮肤瘙痒等临床症状明显改善,无明显并发症,其透析效果远远超出单纯血液透析患者。结论血液灌流是一种安全、有效的方法,配合血液透析使用可以提高患者生存质量,延长患者生命。
Objective To explore the superiority of hemoperfusion （HP） combined with hemodialy sis （HD） （HP/HD） in the treatment of uremia compared with HD only. Method 66 cases treated with HP/HD were analyzed restrospectively. 30 of whom were selected randomly and 30 cases used HD only were chosen as control. We detec- ted descending rate of Scr, BUN and MMS, also the improvement of symptoms, such as sleeping, appetite, hyperten- sion and skin itching, in order to compare their therapeutic efficacy. Rusults After treatment of HP/HD, the level of Scr, BUN and MMS all descended 60% and the clinical symptoms like intractable skin itching reliveved obviously without noticeable complications. The therapeutic efficacy significantly exceeded that of using HD only. Conclusion HP is an effective and safe method, combined with hemodialysis can improve the living quality of patientsand pro- long their life span.
出处
《工企医刊》
2014年第1期579-582,共4页
The Medical Journal of Industrial Enterprise
